Umary-USA.com: Drug Recall

Recall #D-0493-2025 · 05/21/2025

Class I: Dangerous

Recall Details

Recall Number: D-0493-2025
Classification: Class I
Product Type: Drug
Recalling Firm: Umary-USA.com
Status: Ongoing
Date Initiated: 05/21/2025
Location: Nogales, AZ, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1,704 30-count bottles

Reason for Recall

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.

Product Description

UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7503046054134

Distribution Pattern

U.S. Nationwide via internet.

Other Recalls by Umary-USA.com

Class I: Dangerous 05/21/2025

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.

View all recalls by Umary-USA.com →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.